Brookmont Capital Management Novartis Ag Transaction History

Brookmont Capital Management

$194 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 19, 2021	SELL	$85.24 - $94.15 $2.15 Million - $2.37 Million	-25,206 Closed	0 $0
Q1 2021 Apr 15, 2021	SELL	$83.5 - $98.47 $31,479 - $37,123	-377 Reduced 1.47%	25,206 $2.16 Million
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $102,740 - $124,269	-1,316 Reduced 4.89%	25,583 $2.42 Million
Q3 2020 Oct 16, 2020	BUY	$82.14 - $91.0 $47,969 - $53,144	584 Added 2.22%	26,899 $2.34 Million
Q2 2020 Jul 23, 2020	SELL	$80.93 - $91.1 $505,893 - $569,466	-6,251 Reduced 19.19%	26,315 $2.3 Million
Q1 2020 Apr 28, 2020	SELL	$70.67 - $99.01 $183,035 - $256,435	-2,590 Reduced 7.37%	32,566 $2.69 Million
Q4 2019 Jan 22, 2020	SELL	$84.35 - $95.37 $263,509 - $297,935	-3,124 Reduced 8.16%	35,156 $3.33 Million
Q3 2019 Nov 07, 2019	SELL	$85.54 - $94.26 $693,045 - $763,694	-8,102 Reduced 17.47%	38,280 $3.33 Million
Q2 2019 Jul 18, 2019	BUY	$75.4 - $92.8 $26,163 - $32,201	347 Added 0.75%	46,382 $4.24 Million
Q1 2019 Apr 16, 2019	BUY	$75.32 - $86.15 $4,443 - $5,082	59 Added 0.13%	46,035 $4.43 Million
Q4 2018 Feb 12, 2019	BUY	$73.66 - $82.02 $507,812 - $565,445	6,894 Added 17.64%	45,976 $3.95 Million
Q3 2018 Nov 08, 2018	SELL	$66.94 - $77.43 $10,978 - $12,698	-164 Reduced 0.42%	39,082 $3.37 Million
Q2 2018 Jul 19, 2018	BUY	$64.91 - $73.36 $21,679 - $24,502	334 Added 0.86%	39,246 $2.97 Million
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $3.19 Million - $3.82 Million	-45,340 Reduced 53.81%	38,912 $3.15 Million
Q4 2017 Feb 12, 2018	BUY	$72.33 - $77.64 $2.08 Million - $2.24 Million	28,822 Added 52.0%	84,252 $7.07 Million
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $4.11 Million - $4.28 Million	55,430	55,430 $4.76 Million

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookmont Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookmont Capital Management with notifications on news.

Account